HPLC-LED-Induced Fluorescence Analysis of Tear Fluids: An Objective Method for Primary Open Angle Glaucoma Diagnosis

Current diagnostic methods for primary open-angle glaucoma (POAG) often rely on subjective assessments and limited biomarker detection. While tear fluid has been identified as a potential source of diagnostic biomarkers, existing techniques lack the precision needed for reliable protein profiling. Prior research has shown that tear proteins may reflect systemic and ocular health changes, but no method has yet achieved consistent diagnostic accuracy using these proteins. This gap motivated the development of more sensitive and objective analytical tools. Researchers have explored various chromatographic and fluorescence-based methods, but none have been optimized for low-concentration protein detection in tear samples. The lack of a standardized, high-sensitivity platform for tear proteomics remains a significant limitation. Recent advances in LED-induced fluorescence detection have shown promise in improving detection limits for protein analysis. However, no prior work had resolved how to integrate these technologies into a reliable diagnostic system for glaucoma.

This study aimed to evaluate the diagnostic potential of a custom-built HPLC-LED-induced fluorescence (IF) system for analyzing tear proteins in primary open-angle glaucoma (POAG). The researchers sought to determine whether this system could reliably distinguish between tear protein profiles from POAG patients and healthy controls. A specific problem addressed was the low sensitivity of existing methods for detecting low-concentration proteins in tear fluid. The motivation for this work stemmed from the need for an objective, reproducible diagnostic tool for glaucoma. Traditional methods often fail to detect subtle changes in tear proteins that may correlate with disease progression. The team hypothesized that LED-induced fluorescence could enhance detection capabilities. By using multivariate analysis techniques, the researchers aimed to identify patterns unique to POAG. This approach could potentially improve early diagnosis and monitoring of the disease.

The study employed a custom-built HPLC system equipped with a 278 nm LED excitation source for fluorescence detection. Tear fluid samples were collected from both POAG patients and control subjects. Protein separation was achieved using high-performance liquid chromatography. Fluorescence signals were recorded to generate chromatograms for each sample. Multivariate analysis methods were then applied to these data. Principal component analysis (PCA) was used to reduce dimensionality and highlight key protein patterns. A Match/No-Match test was conducted using Mahalanobis distance and spectral residual values. An artificial neural network (ANN) was trained for binary classification of POAG and control samples. The performance of these methods was evaluated using sensitivity and specificity metrics.

The HPLC-LED-IF system achieved a sensitivity of 86.9% and specificity of 81.8% using the Match/No-Match test. The artificial neural network (ANN) method yielded similar results with 87.1% sensitivity and 81.8% specificity. The 278 nm LED excitation provided sufficient sensitivity for detecting low-concentration proteins in tear samples. Chromatograms revealed distinct protein profiles between POAG and control groups. PCA analysis highlighted significant differences in protein patterns between the two groups. Mahalanobis distance calculations confirmed the statistical significance of these differences. The spectral residual values further supported the reliability of the Match/No-Match classification. These findings suggest that the system can reliably detect POAG-specific protein profiles.

The study demonstrated that the HPLC-LED-IF system can detect POAG-specific protein profiles in tear fluid with high sensitivity and specificity. The authors propose that this method offers a reliable and objective diagnostic tool for glaucoma. The use of 278 nm LED excitation was highlighted as a key factor in achieving low-concentration protein detection. The Match/No-Match and ANN methods both showed comparable diagnostic performance. These findings suggest that the system can distinguish between POAG and control samples effectively. The researchers propose that this approach could improve early diagnosis and monitoring of glaucoma. The integration of multivariate analysis techniques enhances the system's ability to detect subtle protein changes. Future work may explore expanding the sample size to validate these results further.